Journal profile · OPHTHALMOLOGY
Journal of Ophthalmic Inflammation and Infection
ISSN 1869-5760 · SpringerOpen · United Kingdom
Journal of Ophthalmic Inflammation and Infection: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2 (journal website); fully open access; APC about USD 2,390; median 92 days to acceptance (93 articles, last 24 months); 107 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Ophthalmic Inflammation and Infection is published by SpringerOpen and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ocular Diseases and Behçet’s Syndrome, Ocular Infections and Treatments and Retinal and Optic Conditions, together about 49.4% of its articles. Its main subfields are Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Ophthalmic Inflammation and Infection is a peer-reviewed open access journal published under the brand SpringerOpen. It presents current clinical and experimental research on a range of ophthalmic inflammation and infection topics. Coverage includes original studies, review articles, brief reports, case reports, photo essays, and expert commentary on challenging cases. The journal reflects geographical variations in incidence of diseases as well as different treatment modalities worldwide. This is the official journal of the International Ocular Inflammation Society (IOIS), and the editorial board includes international experts in the field of ophthalmic inflammation and infection.
From the journal's Aims & Scope
Research area (LetPub): OPHTHALMOLOGY
Editor-in-chief Carlos PavesioPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 8, United Kingdom 4, Japan 4, India 4, France 2 (43 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ocular Diseases and Behçet’s SyndromeMedicine29.1%
- Ocular Infections and TreatmentsMedicine11.9%
- Retinal and Optic ConditionsMedicine8.4%
- Retinal Diseases and TreatmentsMedicine7.2%
- Sarcoidosis and Beryllium Toxicity ResearchMedicine3.9%
- Ocular Surface and Contact LensMedicine3.1%
- Ocular Oncology and TreatmentsMedicine3.1%
- Cytomegalovirus and herpesvirus researchMedicine3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2Publisher website ·
- 5-year impact factor (publisher) 2025
- 2Publisher website ·
- CiteScore 2026-06
- 3LetPub ·
- SJR 2026-06
- 0.69LetPub ·
- SNIP 2026-06
- 1.17LetPub ·
- h-index
- 49OpenAlex ·
- i10-index
- 323OpenAlex ·
- 2-year mean citedness
- 2.06OpenAlex ·
- Self-citation rate
- 5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 101LetPub ·
- Downloads per year (publisher) 2025
- 516800Publisher website ·
Articles by year OpenAlex count · 771 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 72 | 72 | 10 |
| 2025 | 107 | 107 | 186 |
| 2024 | 70 | 70 | 316 |
| 2023 | 55 | 55 | 426 |
| 2022 | 42 | 42 | 496 |
| 2021 | 47 | 47 | 812 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
92 daysMedian, submission to acceptance · P25–P75 60 days – 141 days
- Acceptance to online
- median 18 days (93 articles)
- Submission to online
- median 123 days
- Sample
- 93 articles with submission and acceptance dates (204 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,090 / USD 2,390 / GBP 1,490 | Yes | CC BY | |
| OpenAlex | USD 2,290 / EUR 1,990 / GBP 1,390 | — | — | |
| LetPub | GBP 1,340 / USD 2,190 / EUR 1,890 | Yes | — | |
| Publisher website | GBP 1,490 / USD 2,390 / EUR 2,090 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
- Innovations in Uveitis TreatmentDeadline
What to prepare5 items from the author guidelines
- Reference style
- APA
- Templates
- LaTeX and Word
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted4
- brief reportsThis section provides general style and formatting information only. Formatting guidelines for specific article types can be found below. Research Brief Reports…Length not stated
- matters arisingThis section provides general style and formatting information only. Formatting guidelines for specific article types can be found below. Research Brief Reports…Length not stated
- researchThis section provides general style and formatting information only. Formatting guidelines for specific article types can be found below. Research Brief Reports…Length not stated
- reviewsThis section provides general style and formatting information only. Formatting guidelines for specific article types can be found below. Research Brief Reports…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright, Open access, Peer review
- Authorship
A manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party. Model summary
Please note that a manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Source ↗Publisher website ·- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Authors are strongly encouraged or required to provide all datasets on which the conclusions of their manuscripts rely. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access articles are published under a CC BY licence (Creative Commons Attribution 4.0 International licence). Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Journal of Ophthalmic Inflammation and Infection articles are published open access under a CC BY licence (C…
Source ↗Publisher website ·- Open access Benefits of open access
Authors retain copyright of their articles. Model summary
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SpringerOpen
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1869-5760
- Society / sponsor
- International Ocular Inflammation Society
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Ophthalmic Inflammation and Infection
What CAS zone is Journal of Ophthalmic Inflammation and Infection in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Ophthalmic Inflammation and Infection is in Zone 4 of Medicine, and in Zone 3 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Ophthalmic Inflammation and Infection?
The journal's website gives an impact factor of 2 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3, h-index 49.
How long does peer review take at Journal of Ophthalmic Inflammation and Infection?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 60–141 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Ophthalmic Inflammation and Infection?
According to the journal's author guidelines: Reference style: APA; Templates: LaTeX and Word; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Ophthalmic Inflammation and Infection based?
Of the 43 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (8), United Kingdom (4) and Japan (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Ophthalmic Inflammation and Infection?
According to LetPub and DOAJ records, Journal of Ophthalmic Inflammation and Infection is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Journal of Ophthalmic Inflammation and Infection open access, and what is the APC?
Journal of Ophthalmic Inflammation and Infection is a fully open-access journal. APC about USD 2,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .